USC PhD student Ruzanna “Rose” Shkhyan has gotten a first-hand look at how stem cell discoveries can lead to clinical trials. As member of the USC Stem Cell laboratory of Denis Evseenko, she contributed research that led to the development of a therapeutic agent that can modulate inflammation, which will be in a clinical trial in early 2021 to treat osteoarthritis.

“My studies uncoupled degenerative versus regenerative functions of pro-inflammatory signaling in osteoarthritis, and how this chronic, low-grade inflammation can be modulated by molecular, genetic, and pharmacological approaches,” she said.

To read more, visit https://stemcell.keck.usc.edu/usc-stem-cell-phd-student-ruzanna-rose-shkhyan-works-to-end-inflamm-aging/.